First Wave BioPharma, Inc. insider trading activity

Understanding Insider Activity at First Wave BioPharma, Inc.

Welcome to our dedicated page for First Wave BioPharma, Inc. (Nasdaq: ENTO) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by First Wave BioPharma, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for First Wave BioPharma, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for ENTO
TickerTime & DateFilingLink
ENTO09:00:12 PM, 10/10/2024
Romano Sarah(Chief Financial Officer) sold 476 shares of Entero Therapeutics, Inc. (ENTO) for ~$214
Filing
ENTO06:34:36 PM, 07/03/2024
Romano Sarah(Chief Financial Officer) sold 621 shares of Entero Therapeutics, Inc. (ENTO) for ~$664
Filing
ENTO06:33:15 PM, 07/03/2024
SAPIRSTEIN JAMES(Chairman and CEO) sold 1289 shares of Entero Therapeutics, Inc. (ENTO) for ~$1379
Filing